ReviewIn vivo (Athens, Greece)
Appendiceal Tumors: A Narrative Review.
Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Clinical and Laboratory Parameters with Appendiceal Neoplasms in Acute Appendicitis: A Single-Institution Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Appendiceal tumors (ATs) are classified by the World Health Organization's (WHO) 5th edition of their categorization of digestive system tumors into four subtypes: mucinous neoplasms, adenocarcinomas, serrated lesions, polyps, and neuroendocrine neoplasms (NENs). Due to their rarity and the lack of data from randomized controlled studies, ATs can be challenging to differentiate in medical practice. Specimens obtained during appendectomies for clinically acute appendicitis typically contain ATs. Most ATs in the European population affect women over 50 years. Neuroendocrine tumors (NETs) are the most common histological type, comprising 54.6%, followed by cystic, mucinous, and serous neoplasms (26.7%) and adenocarcinoma not otherwise defined (NOS) (18.6%). Most findings of ATs on pathologic investigation are benign lesions or small NENs that do not require additional treatment. The development of pseudomyxoma peritonei (PMP), a complicated situation of peritoneal carcinomatosis, may result from the presence of appendiceal mucinous neoplasm (AMN). Over the past few decades, multimodal treatment for abdominal cancers has advanced; however, ATs' clinical diagnosis and management are still debated. This review aims to outline the diagnostic options, molecular-based diagnosis, staging, treatment, and prognostic markers related to ATs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.